Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

NPPA Hikes Price of Cholesterol-Lowering Drug Atorvastatin

Farhat Nasim25 Nov 2024 6:23 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently revised the ceiling price of Atorvastatin 10 mg, a widely used...

Investigation Lapses Lead to Acquittal in Hospital Voyeurism Case

SEBI Slaps Rs 25L Fine, 1-Year Market Ban on 2 Individuals For Insider Trading in Jagsonpal Pharma

Farhat Nasim25 Nov 2024 5:04 PM IST

NSE analyzed JPL trades, flagged patterns suggesting insider trading based on UPSI deemed price-sensitive, leading to action.

USFDA Inspection: Alembic Pharma gets form 483 with 5 procedural observations for Gujarat plant

Farhat Nasim25 Nov 2024 3:47 PM IST

The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility.

Gilead Sciences, Kymera Therapeutics ink pact

Aurobindo Pharma Partners with Global Pharma Major for Respiratory Product Development

Farhat Nasim25 Nov 2024 3:36 PM IST

As per the pact, both parties will co-exclusively commercialise the products.

D Pharm Studens Unlicensed Store Busted in Haryana, ACB Arrests Drug Official During Raid

Raid: Telangana DCA Seizes Cefuroxime, Dexamethasone, Other Antibiotics, Steroids from Unlicensed Clinic

Farhat Nasim25 Nov 2024 3:26 PM IST

DCA officials also detected certain medicines circulating in the market with misleading claims on their labels.

Himachal HC Orders Investigation into Spurious Drugs Production at Baddi Pharma Units

Farhat Nasim25 Nov 2024 2:43 PM IST

The complaint alleged that medicine Feracrylum API and 1 percent Feracrylum gel, which are homeostatic polymers, were not as per prescribed formula.

Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal

Abbott's Plea Alleging NPPA Used Outdated PTR Data for Metoprolol Pricing Rejected by DoP

Farhat Nasim24 Nov 2024 11:00 AM IST

New Delhi: A review application filed by Abbott Healthcare, alleging that the National Pharmaceutical Pricing Authority (NPPA) used lower...

Eli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight Loss

Farhat Nasim24 Nov 2024 11:00 AM IST

Bengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while...

Despite Pluvicto, MorphoSys Setbacks, Novartis Raises 2028 Sales Growth Outlook to 6%

Farhat Nasim24 Nov 2024 10:30 AM IST

Frankfrut: Novartis raised its medium-term sales guidance on Thursday to 6 percent annual growth through 2028, driven by momentum of launched...

Like USFDA, we need Bharat Food and Drug Administration for global benchmarks, says FM Sitharaman

Farhat Nasim24 Nov 2024 9:30 AM IST

Bengaluru: India is setting standards in pharmaceuticals and like the US Food and Drug Administration (FDA), we should also aim to create Bharat Food...

DCGI Warns Cosmetic Industry Against Overlapping Claims With Pharma Products

Farhat Nasim23 Nov 2024 3:07 PM IST

New Delhi: The Drugs Controller General of India (DCGI) has issued a stern warning to the cosmetics industry to adhere to strict regulatory...

Dr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment

Farhat Nasim23 Nov 2024 1:45 PM IST

The companies have committed to invest over Rs 5,260 crore, which is expected to create 12,490 job opportunities in the pharma sector

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok